Ghadeer S Aljuraiban1,2, Jeremiah Stamler3, Queenie Chan2, Linda Van Horn3, Martha L Daviglus3, Paul Elliott2, Linda M Oude Griep2. 1. Department of Community Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Kingdom of Saudi Arabia. 2. MRC-PHE Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, Norfolk Place, London, UK. 3. Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Evanston, Chicago, Illinois, USA.
Abstract
BACKGROUND: Epidemiologic evidence suggests that low-fat dairy consumption may lower risk of hypertension. Dairy products may be distinctly linked to health, because of differences in nutritional composition, but little is known about specific nutrients that contribute to the dairy-blood pressure (BP) association, nor to underlying kidney function. METHODS: We examined cross-sectional associations to BP of dairy product intakes, total and by type, from the INTERnational study on MAcro/micronutrients and blood Pressure (INTERMAP) including 2694 participants aged 40-59 years from the UK and the USA. Eight BP, four 24-h dietary recalls and two 24-h urine samples were collected during four visits. Linear regression models adjusted for lifestyle/dietary factors to estimate BP differences per 2SD higher intakes of total-and-individual-types of dairy were calculated. RESULTS: Multivariable linear regression coefficients were estimated and pooled. In contrast to total and whole-fat dairy, each 195 g/1000 kcal (2SD) greater low-fat dairy intake was associated with a lower SBP -2.31 mmHg and DBP -2.27 mmHg. Significant associations attenuated with adjustment for dietary phosphorus, calcium, and lactose, but strengthened with urinary calcium adjustment. Stratification by median albumin-creatinine ratio (ACR; high ACR indicates impaired kidney function) showed strong associations between low-fat dairy and BP in participants with low ACR (SBP: -3.66; DBP: -2.15 mmHg), with no association in participants with high ACR. CONCLUSION: Low-fat dairy consumption was associated with lower BP, especially among participants with low ACR. Dairy-rich nutrients including phosphorus and calcium may have contributed to the beneficial associations with BP.
BACKGROUND: Epidemiologic evidence suggests that low-fat dairy consumption may lower risk of hypertension. Dairy products may be distinctly linked to health, because of differences in nutritional composition, but little is known about specific nutrients that contribute to the dairy-blood pressure (BP) association, nor to underlying kidney function. METHODS: We examined cross-sectional associations to BP of dairy product intakes, total and by type, from the INTERnational study on MAcro/micronutrients and blood Pressure (INTERMAP) including 2694 participants aged 40-59 years from the UK and the USA. Eight BP, four 24-h dietary recalls and two 24-h urine samples were collected during four visits. Linear regression models adjusted for lifestyle/dietary factors to estimate BP differences per 2SD higher intakes of total-and-individual-types of dairy were calculated. RESULTS: Multivariable linear regression coefficients were estimated and pooled. In contrast to total and whole-fat dairy, each 195 g/1000 kcal (2SD) greater low-fat dairy intake was associated with a lower SBP -2.31 mmHg and DBP -2.27 mmHg. Significant associations attenuated with adjustment for dietary phosphorus, calcium, and lactose, but strengthened with urinary calcium adjustment. Stratification by median albumin-creatinine ratio (ACR; high ACR indicates impaired kidney function) showed strong associations between low-fat dairy and BP in participants with low ACR (SBP: -3.66; DBP: -2.15 mmHg), with no association in participants with high ACR. CONCLUSION: Low-fat dairy consumption was associated with lower BP, especially among participants with low ACR. Dairy-rich nutrients including phosphorus and calcium may have contributed to the beneficial associations with BP.
Authors: Lawrence J Appel; Michael W Brands; Stephen R Daniels; Njeri Karanja; Patricia J Elmer; Frank M Sacks Journal: Hypertension Date: 2006-02 Impact factor: 10.190
Authors: F M Sacks; L P Svetkey; W M Vollmer; L J Appel; G A Bray; D Harsha; E Obarzanek; P R Conlin; E R Miller; D G Simons-Morton; N Karanja; P H Lin Journal: N Engl J Med Date: 2001-01-04 Impact factor: 91.245
Authors: Andrew Mente; R John D' A Honey; John M McLaughlin; Shelley B Bull; Alexander G Logan Journal: J Am Soc Nephrol Date: 2006-07-19 Impact factor: 10.121
Authors: Alan R Dyer; Philip Greenland; Paul Elliott; Martha L Daviglus; George Claeys; Hugo Kesteloot; Hirotsugu Ueshima; Jeremiah Stamler Journal: Am J Epidemiol Date: 2004-12-01 Impact factor: 4.897
Authors: Marieke B Snijder; Rob M van Dam; Coen D A Stehouwer; Gerrit J Hiddink; Robert J Heine; Jacqueline M Dekker Journal: Obesity (Silver Spring) Date: 2008-01-17 Impact factor: 5.002
Authors: B Dennis; J Stamler; M Buzzard; R Conway; P Elliott; A Moag-Stahlberg; A Okayama; N Okuda; C Robertson; F Robinson; S Schakel; M Stevens; N Van Heel; L Zhao; B F Zhou Journal: J Hum Hypertens Date: 2003-09 Impact factor: 3.012